Constellation Brands Schedules Q2 Fiscal 2027 Earnings Release for October 6

Constellation Brands (NYSE: STZ) announced that it will release its second quarter fiscal year 2027 financial results on October 6, 2026, after the market closes. The company will also host an accompanying earnings conference call on October 7 at 8:00 a.m. Eastern Time.

This announcement was made in a press release dated September 10, 2026, as listed on the company’s investor-relations website. It provides a precise update on the timing of the company’s next investor event. While this is a routine disclosure, it gains significance as investors look ahead to company performance amid evolving consumer trends in the alcoholic beverages sector.

No other material developments involving Constellation Brands or its stock that meet the criteria of verified, highly relevant events have surfaced in the past week. Specifically, there have been no fresh earning surprises, major strategic shifts, leadership changes, M&A announcements, regulatory actions, or other events with direct and substantial implications for the company’s fundamentals or share price within this timeframe.

Investors and analysts will closely watch the company’s second quarter earnings for updates on:

• Performance across its beer and wine & spirits segments, particularly volume and net sales trends
• Free cash flow generation and capital allocation plans, including share repurchases or dividend policy updates
• Any commentary on consumer demand trends, especially in key markets or demographic segments

The upcoming earnings release represents the most relevant and timely development for STZ in the past week. It will likely shape the near-term investor outlook and provide much-needed insight into how Constellation Brands is navigating consumer behavior shifts and economic conditions.

Constellation’s stock price was last verified as $112.92, down 0.51%, as of September 28, 2026. Any market reaction around October 6–7 should be evaluated in light of the company’s actual financial results and commentary, rather than speculative expectations.